SPCE

Virgin Galactic is not an operating business right now — it's a development project trading at 142x sales on $1.54M of FY2025 revenue, which itself collapsed 78% YoY because commercial service was paused in mid-2024. The 10-K is explicit: flight testing only 'commences in the third quarter of 2026' with commercial service 'expected to begin in the fourth quarter of 2026 with a research flight,' and private astronaut flights six-to-eight weeks after that. So the market is paying a $220M equity valuation for a company whose product line is entirely dependent on next-generation spaceships that have not yet flown, on a timeline the company itself frames as forward-looking and risk-laden.

The balance sheet cannot support this runway comfortably. FY2025 operating cash flow was -$240M and capex was $198M, implying roughly $438M of annual cash consumption against just $145M of cash and equivalents on hand (down 19% YoY). Even including all $373M of current assets, the company is spending faster than its liquid resources can cover, and the December 2025 repurchase of $354.6M of 2027 convertible notes — while cutting long-term debt 34% to $276M — consumed capital and did not solve the burn. The tell is in the share count: diluted shares are up 129% YoY, and accumulated deficit sits at -$2.75B. Continued flights before revenue almost certainly require further dilutive equity or debt raises at a depressed $2.70 price, directly against existing holders.